Vaishali Pharma Stock Screener | Share Price & Fundamental Analysis
VAISHALI
Pharmaceuticals
Share Price NSE
₹6.79
▼
-0.18 (-2.58%)
Track Vaishali Pharma share price live with TickJournal's free stock screener.
Analyze Vaishali Pharma share price history trends and compare 52-week high low
levels.
Calculate VAISHALI stock fair value using fundamental analysis and view live share price charts.
Determine Vaishali Pharma share intrinsic value and compare it with current VAISHALI share price.
Record your Vaishali Pharma trades in TickJournal's free trading journal and track your portfolio performance.
Vaishali Pharma Market Cap
₹99.58 Cr.
VAISHALI P/E Ratio (TTM)
15.00
EPS (TTM)
₹0.06
Dividend Yield
-
Debt to Equity
0.24
VAISHALI 52 Week High
₹14.78
Vaishali Pharma 52 Week Low
₹6.79
Operating Margin
6.00%
Profit Margin
4.00%
VAISHALI Revenue (TTM)
₹25.00
EBITDA
₹2.00
Net Income
₹1.00
Total Assets
₹110.00
Total Equity
₹65.00
Vaishali Pharma Share Price History - Stock Screener Chart
Screen VAISHALI historical share price movements with interactive charts. Analyze price trends and patterns.
Vaishali Pharma Company Profile - Fundamental Screener
Screen Vaishali Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for VAISHALI shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE972X01022
Vaishali Pharma Balance Sheet Screener
Screen VAISHALI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total Assets | 110 | 80 | 79 | 82 | 86 | 66 | 69 | 64 | 45 |
| Current Assets | 105 | 75 | 73 | 76 | 81 | 61 | 63 | 59 | 40 |
| Fixed Assets | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 1 |
| Liabilities | |||||||||
| Total Liabilities | 110 | 80 | 79 | 82 | 86 | 66 | 69 | 64 | 45 |
| Current Liabilities | 5 | 4 | 6 | 3 | 4 | 4 | 5 | 3 | 4 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||||
| Total Equity | 65 | 43 | 41 | 26 | 22 | 21 | 21 | 21 | 4 |
| Share Capital | 26 | 11 | 11 | 11 | 11 | 11 | 7 | 7 | 3 |
| Reserves & Surplus | 39 | 32 | 30 | 16 | 12 | 11 | 15 | 14 | 1 |
Vaishali Pharma Income Statement Screener - Profit & Revenue Analysis
Screen Vaishali Pharma income statement and profit fundamentals.
Analyze VAISHALI quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Vaishali Pharma share price evaluation.
| Item | 2025-Jun | 2025-Sept |
|---|---|---|
| Revenue | 25 | 34 |
| Expenses | 22 | 32 |
| EBITDA | 2 | 2 |
| Operating Profit % | 6.00% | 4.00% |
| Depreciation | 0 | 0 |
| Interest | 0 | 0 |
| Profit Before Tax | 2 | 2 |
| Tax | 1 | 1 |
| Net Profit | 1 | 1 |
| EPS | 0.10 | 0.09 |
Vaishali Pharma Cash Flow Screener - Liquidity Fundamentals
Screen VAISHALI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -18 | 1 | 1 | 1 | 2 | 3 | 4 | -10 | 1 | 5 |
| Investing Activities | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 1 | 1 | 3 |
| Financing Activities | 19 | -1 | -2 | 0 | -2 | -3 | -4 | 9 | -1 | -8 |
| Net Cash Flow | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Vaishali Pharma Shareholding Pattern Screener
See Vaishali Pharma shareholding pattern with promoter, FII, and DII holdings.
Check Vaishali Pharma promoter holding and ownership changes for VAISHALI on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-May | 2024-Jun | 2024-Jul | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 26.32% | 26.32% | 26.32% | 26.32% | 24.87% | 26.32% | 31.61% | 26.32% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 65.24% | 65.88% | 67.25% | 62.93% | 66.66% | 66.11% | 62.17% | 64.98% |
| Other Holding | 8.44% | 7.80% | 6.43% | 10.74% | 8.46% | 7.57% | 6.22% | 8.70% |
| Shareholder Count | 28,874 | 28,682 | 27,752 | 9,390 | 10,296 | 9,479 | 9,479 | 18,983 |
Vaishali Pharma Share Dividend Screener - Share Yield Analysis
Check Vaishali Pharma dividend history with payout and yield data.
View Vaishali Pharma dividend details including ex-dates and amounts for VAISHALI stock.
Vaishali Pharma Stock Index Membership
See which indices include Vaishali Pharma stock.
Check VAISHALI index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Vaishali Pharma Market Events Screener - Corporate Actions
Get Vaishali Pharma corporate actions including splits, bonuses, and buybacks.
Check Vaishali Pharma stock events that may affect VAISHALI share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 19.02% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -1.85% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | -4.93% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -1.61% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 4.37% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -8.12% |
| 2024-10-15 | 2024-10-15 | Bonus | 1:1 | -2.49% |
| 2024-10-15 | 2024-08-28 | Split | 2:10 | 0.00% |
| 2019-10-17 | Bonus | 3:5 | - |
Vaishali Pharma Competitors Screener - Peer Comparison
Screen VAISHALI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Vaishali Pharma Company Announcements - News Screener
Screen VAISHALI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-09 | General Updates | View |
| 2025-11-17 | Copy of Newspaper Publication | View |
| 2025-11-14 | Outcome of Board Meeting | View |
| 2025-11-14 | Outcome of Board Meeting | View |
| 2025-10-14 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | View |
| 2025-10-14 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | View |
| 2025-09-23 | Change in Management | View |
| 2025-09-23 | Shareholders meeting | View |